Design Defect, Failure-To-Warn Claims in Jardiance Case Not Preempted, Ind. Federal Judge Rules
September 11, 2017
DOCUMENTS
- Order
INDIANAPOLIS — An Indiana federal judge has allowed failure-to-warn and design defect claims to proceed against Boehringer Ingelheim in a Jardiance action, finding they are not preempted because Boehringer did not show that the FDA would have rejected any proposed changes to the label.
However, in the Sept. 7 opinion, Judge Sarah E. Baker of the U.S. District Court for the Southern District of Indiana dismissed the claims against defendant Eli Lilly & Co., finding they are preempted because Lilly is not the Jardiance New Drug Application holder and thus could not unilaterally make changes to the drug’s label.
Tanya …
FIRM NAMES
- Hovde Dassow & Deets
- Ice Miller
- Katz Korin Cunningham
- Pepper Hamilton
- SIdley Austin
UPCOMING CONFERENCES
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo
HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates
May 29, 2024 - Salt Lake City, UT
The Grand America Hotel